Recent articles
Why BioCryst Pharmaceuticals Rose 8% on Thursday
The company's first commercial drug launch keeps exceeding expectations.
Here's Why Ampio Pharmaceuticals Stock Is Surging Today
A positive second-quarter earnings report and anticipation of further details to be discussed this afternoon helped this beaten-down biotech stock recover some previous losses.
3 Unstoppable Healthcare Stocks to Buy Now and Hold Forever
Here are some terrific options for investors who just want to set it and forget it.
3 High-Growth Healthcare Stocks to Buy in August
These potential stock rockets are well worth the different risks they present.
Here's Why TG Therapeutics Stock Is Getting Hammered Today
A second-quarter earnings report reminded investors how difficult it is for independent companies to launch new cancer drugs.
Here's Why Autolus Therapeutics Is Surging Today
Potential licensing agreements with Moderna are giving investors reasons to cheer.
Is Align Technology a Buy After a Blowout Second Quarter?
The leading provider of clear aligners is firing on all cylinders right now.
Here's Why Novocure Dipped 19% This Week
Uptake of the company's revolutionary disease-controlling device isn't progressing as quickly as expected.
Here's Why Annovis Bio, Anavex Life Sciences, and Cassava Sciences Sank on Thursday
A clinical-trial flop for Annovis Bio is reminding investors that developing new drugs for Alzheimer's disease is an extremely risky business.
Can Teladoc Health Stock Start Climbing Again?
Slowing growth in the face of exploding competition for digital health services should have investors more than a little concerned.
Here's Why Myovant Sciences Stock Is Falling Today
Second-quarter earnings results were a little bit disappointing.
Here's Why Relmada Therapeutics Stock Popped Today
Results from a human abuse potential study with REL-1017 exceeded expectations.
Here's Why NRx Pharmaceuticals Stock Dropped Monday
After soaring for a couple of days this popular COVID-19 stock fell back.
2 Beaten-Down Biotech Stocks That Could Bounce Back
The market hasn't been kind to these two drugmakers, but both have a chance to turn things around.
3 Biotech Stocks That Could Rocket Higher
Over the past year, these small-cap drugmakers have done well by their shareholders, and more big catalysts could be coming.
Here's Why Alzamend Neuro Stock Is Shooting Higher Today
There's never been a better time to be a mouse with Alzheimer's disease.
Here's Why Cassava Sciences Is Surging Today
Investors are excited about upcoming presentations scheduled for the annual Alzheimer's Association International Conference.
3 Biotech Stocks That Could Double Soon
Wall Street analysts following these drugmakers think they can produce big gains in a short time frame.
Here's Why Cytokinetics Is Rocketing Higher Today
The company's new heart drug candidate produced encouraging clinical trial results.
3 Stocks to Buy in the Upcoming Market Crash
Recurring revenue and network effects make these terrific stocks to buy on the dips.